Skip to main content

Amylyx Pharmaceuticals Inc. Common Stock (AMLX)

About The Company

AMLX Stock Market Logo

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases.

IPO Year Sector Industry
2022 Health Care Biotechnology: Pharmaceutical Preparations

Amylyx Pharmaceuticals Inc. (AMLX) Latest News

Company Contact & Address (AMLX)

Corporate Headquarters Phone Website
United States
+1 617 682-0917 Official AMLX Website

AMLX Key Executives

Ownership and management information.

Key Data Points*

Exchange Not Available Market Cap Not Available
Sector Health Care P/E Ratio Not Available
Industry Biotechnology: Pharmaceutical Preparations Forward P/E 1 Yr. Not Available
1 Year Target Not Available Earnings Per Share (EPS) Not Available
Today’s High/Low Not Available Annualized Dividend Not Available
Share Volume Not Available Ex Dividend Date Not Available
Average Volume Not Available Dividend Pay Date Not Available
Previous Close Not Available Current Yield Not Available
52 Week High/Low Not Available Beta Not Available

* Information and data may delayed

Officers & Directors @ AMLX

Jobs & Employment at Amylyx Pharmaceuticals Inc.

LinkedIn Company Page
Official Career & Employment Page Employment, Jobs & Careers at Amylyx Pharmaceuticals Inc. (AMLX)

Related & Similar Stock Symbols

SP Stock Market Price & News


SP Plus Corporation Common Stock

BLCM Stock Market Price & News


Bellicum Pharmaceuticals Inc. Common Stock

SRDX Stock Market Price & News


Surmodics Inc. Common Stock